APOLLO HOSPITALS ENTERPRISE LTD.

Apollo Hospitals Enterprise Ltd has announced that its Board of Directors will convene on August 12, 2026. The primary agenda item is the consideration and approval of the unaudited financial results, both standalone and consolidated, for the first quarter ended June 30, 2026. Additionally, the meeting will address other related matters. In line with SEBI regulations, the trading window for promoters, directors, and designated employees will remain closed from July 1, 2026, until 48 hours after the announcement of the financial results, extending up to August 14, 2026.

Apollo Hospitals Enterprise Limited conducted meetings of its equity shareholders, secured creditors, and unsecured creditors on June 24, 2026, as directed by the National Company Law Tribunal (NCLT), Chennai Bench. The meetings were held to approve a composite scheme of arrangement involving Apollo Hospitals Enterprise Limited, Apollo Health co Limited, Keimed Private Limited, and Apollo Healthtech Limited. The voting results and scrutinizer's reports for these meetings, which covered a special resolution for the scheme, have been made available on the company's website and NSDL's e-voting portal. The voting period for remote e-voting was from June 20-23, 2026, with e-voting also conducted during the meeting on June 24, 2026.

Apollo Hospitals Enterprise Ltd has submitted a filing to the National Stock Exchange and Bombay Stock Exchange. The filing, dated June 25, 2026, is accompanied by an annexure. The company's CIN is L85110TN1979PLC008035. The filing was digitally signed by Sankaranarayanan Muthu Krishnan.

Apollo Hospitals Enterprise Limited held meetings of its secured creditors, unsecured creditors, and equity shareholders on June 24, 2026. These meetings, conducted via video conferencing as directed by the National Company Law Tribunal (NCLT), Chennai Bench, were to consider and approve a composite scheme of arrangement. The scheme involves Apollo Hospitals Enterprise Limited, Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited. Summaries of the proceedings for each meeting are enclosed. Details of voting results will be submitted separately.

Apollo Hospitals Enterprise Ltd has provided further clarification regarding the Composite Scheme of Arrangement for the separation and independent listing of Apollo Healthtech Limited. The company reiterated that Rasmeli Limited and the promoter/promoter group of Apollo Healthtech are committed to waiving their rights to nominate directors if their respective shareholdings fall below 10%. Additionally, they have committed to waiving rights to nominate directors in excess of a specified number based on their aggregate shareholding, with thresholds ranging from 0 directors for below 10% shareholding to up to 5 directors for 35% and above. These provisions will be incorporated into Apollo Healthtech's Articles of Association after the Scheme becomes effective. The company believes the Scheme will unlock value and position Apollo Healthtech for future growth.

Apollo Hospitals Enterprise Ltd. has provided additional information regarding the Composite Scheme of Arrangement for the separation and independent listing of Apollo Healthtech. The filing details the proposed governance framework for Apollo Healthtech, emphasizing transparency and robust decision-making. Key aspects include ensuring half of the Board comprises independent directors as per SEBI LODR Regulations, and outlining board nomination rights for investors and promoters. The company asserts that these arrangements are market practice and do not prejudice other shareholders, aiming to preserve continuity, stability, and long-term value creation for all stakeholders. The Upside Agreement is noted as entirely investor-funded, with no dilution to Apollo Healthtech's resources.

Apollo Hospitals Enterprise Ltd has scheduled a meeting for its secured creditors on June 24, 2026, to consider and approve a composite scheme of arrangement. This scheme involves the demerger of Apollo Hospitals Enterprise Ltd into Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited. The meeting will be conducted via Video Conferencing/Other Audio Visual Means, with remote e-voting available from June 20-23, 2026. The company has appointed NSDL to facilitate the e-voting process.

Dinesh Madhavan has resigned from his position as President - Group Oncology and International of Apollo Hospitals Enterprise Limited, effective from the close of business hours on May 30, 2026. The resignation was mutually agreed upon, and May 30th, 2026, will be his last working day.

Apollo Hospitals Enterprise Ltd. announced the publication of an advertisement regarding NCLT convened meetings. The company dispatched notices, a scheme copy, and explanatory statements to equity shareholders as of May 15, 2026. Remote e-voting will be available from June 20, 2026, to June 23, 2026. NCLT appointed Dr. K. S. Ravichandran as Chairperson and Mr. S. Vedhavel as Scrutinizer for the meeting and e-voting process, respectively. The scheme's approval is subject to NCLT and public shareholder consent.

Apollo Hospitals Enterprise Ltd will hold a meeting of equity shareholders on June 24, 2026, via video conferencing to consider and approve a composite scheme of arrangement. This scheme involves Apollo Hospitals, Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited, along with their respective shareholders and creditors. The meeting is pursuant to Tribunal Orders passed in Company Application (CAA) No. 8/CHE/2026. Notice of the meeting and explanatory statements have been sent to shareholders electronically and via speed post. Remote e-voting will be available from June 20-23, 2026, through NSDL.